The Bank of Nova Scotia (BNS) Presents at RBC Capital Markets Global Financial Institutions Conference (Transcript)
RBC Capital Markets Global Financial Institutions Conference March 5, 2025 8:40 AM ETCompany ParticipantsPhil Thomas ...
Judge dismisses shareholder lawsuit against Intel over Foundry woes
A judge dismissed a shareholder lawsuit against Intel (INTC) in a case that alleged the chipmaker had misled the plaintiffs ...
2INTC : What's Going On With Intel Shares Wednesday?
Intel Corporation INTC stock is moving lower on Wednesday. Weakness in the stock may be due to President Donald Trump ‘s call ...
Intel defeats shareholder lawsuit over foundry losses, $32 billion plunge
Intel won the dismissal of a shareholder lawsuit accusing the chipmaker of fraudulently concealing problems in its foundry ...
2INTC : Intel's Options: A Look at What the Big Money is Thinking
Analyzing the Volume and Open Interest in these contracts, it seems that the big players have been eyeing a price window from $18.0 to $60.0 for Intel during the past quarter. Looking at the volume ...
Stocktwits on MSN1h
Intel Reportedly Dodges Shareholder Lawsuit, But Stock Continues Slide As Trump Moves To Kill Chips Act – Retail’s Divided
Intel (INTC) reportedly won the dismissal of a shareholder lawsuit that accused the company of concealing problems in its ...
Intel's stock is skidding toward its longest losing streak in 7 months. Here's why.
The Intel Corp. fever has been cooling in recent days, with the stock in the midst of a three-day losing streak as investors try to make sense of the latest political developments and what they mean ...
3 Growth Stocks to Buy Now Even If There's a Stock Market Sell-Off
Market volatility has picked up, but it's still too early to call a stock market sell-off. After all, the Nasdaq Composite ...
Forbes on MSN46m
Victoria’s Secret Tweaks DEI Language To ‘Inclusion And Belonging’: Here Are All The Companies Rolling Back DEI Programs
Following Trump's lead, organizations including Walmart, Lowe’s and Meta have announced they would scale back their ...
ResMed upgraded to Buy from Neutral at Citi
Citi upgraded ResMed (RMD) to Buy from Neutral with a price target of A$44, up from A$41. The firm likes the stock’s “reasonable valuation, ...
ResMed price target lowered to $240 from $250 at Stifel
Stifel lowered the firm’s price target on ResMed (RMD) to $240 from $250 and keeps a Hold rating on the shares. After having gathered survey ...
US drivers log 3.28 trillion miles in 2024, setting new record
Travel on U.S. roads in 2024 rose 1% to 3.28 trillion miles setting a new yearly record and topping pre-COVID 19 levels for ...